In the past two decades, immunotherapy has rapidly developed and revolutionized the treatment of various types of cancer. Domenica Lorusso, MD, PhD, Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy, explores the role of immuno-oncology in the treatment landscape of ovarian cancer and highlights the importance of identifying patients that are likely to respond to immune checkpoint blockade. This interview took place at the ESMO Gynaecological Cancers Virtual Congress 2021.
